These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17192365)

  • 41. [Anti-diabetic treatment, insulin resistance and cardiovascular disease in patients with type 2 diabetes].
    Hemmingsen B; Lund SS; Vaag A
    Ugeskr Laeger; 2009 May; 171(19):1598-602. PubMed ID: 19419642
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Introduction to hyperglycaemic peaks.
    Standl E
    Int J Clin Pract Suppl; 2002 Jul; (129):2. PubMed ID: 12166600
    [No Abstract]   [Full Text] [Related]  

  • 43. Coeliac disease and its relation to glycaemic control in adults with type 1 diabetes mellitus.
    Depczynski B
    Diabetes Res Clin Pract; 2008 Jan; 79(1):e10. PubMed ID: 17681392
    [No Abstract]   [Full Text] [Related]  

  • 44. Sustained IL-1alpha, IL-4, and IL-6 elevations following correction of hyperglycemia in children with type 1 diabetes mellitus.
    Rosa JS; Flores RL; Oliver SR; Pontello AM; Zaldivar FP; Galassetti PR
    Pediatr Diabetes; 2008 Feb; 9(1):9-16. PubMed ID: 18211631
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vascular risks and complications in diabetes mellitus: the role of helicobacter pylori infection.
    Hamed SA; Amine NF; Galal GM; Helal SR; Tag El-Din LM; Shawky OA; Ahmed EA; Abdel Rahman MS
    J Stroke Cerebrovasc Dis; 2008; 17(2):86-94. PubMed ID: 18346651
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mauriac syndrome: growth failure and type 1 diabetes mellitus.
    Kim MS; Quintos JB
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():989-93. PubMed ID: 18806715
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The mechanisms responsible for the development of diabetic nephroangiopathy].
    Saltykov BB
    Arkh Patol; 2008; 70(5):38-42. PubMed ID: 19137784
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Can good blood sugar regulation prevent diabetic complications?].
    Dahl-Jørgensen K; Hanssen KF
    Nord Med; 1988; 103(12):343-4. PubMed ID: 3200703
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of a controlled hypoglycaemia test on QTc in adolescents with Type 1 diabetes.
    Rothenbuhler A; Bibal CP; Le Fur S; Bougneres P
    Diabet Med; 2008 Dec; 25(12):1483-5. PubMed ID: 19046250
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Postchallenge hyperglycaemic spike associate with arterial stiffness.
    Huang CL; Chen MF; Jeng JS; Lin LY; Wang WL; Feng MH; Liau CS; Hwang BS; Lee YT; Su TC
    Int J Clin Pract; 2007 Mar; 61(3):397-402. PubMed ID: 17313605
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
    Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
    Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High day-to-day glucose variability: a frequent phenomenon in children and adolescents with type 1 diabetes attending summer camp.
    Choleau C; Aubert C; Cahané M; Reach G
    Diabetes Metab; 2008 Feb; 34(1):46-51. PubMed ID: 18206413
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Growth hormone and diabetic angiopathy].
    Müller R
    Hippokrates; 1971 Dec; 42(4):518-9. PubMed ID: 5157328
    [No Abstract]   [Full Text] [Related]  

  • 54. [Development and prevention of diabetic microangiopathy: is blood sugar compensation enough?].
    Tagliabue M
    Clin Ter; 1986 Nov; 119(4):275-82. PubMed ID: 3542348
    [No Abstract]   [Full Text] [Related]  

  • 55. Diabetic choroidal involvement: scanning electron microscopy study.
    Fryczkowski AW
    Klin Oczna; 1988; 90(4-5):145-9. PubMed ID: 2468011
    [No Abstract]   [Full Text] [Related]  

  • 56. [Complex measures (yellow turpentine baths and interference currents) in the treatment of patients with diabetes mellitus with micro- and macroangiopathies].
    Turova EA; Davydova OB; Gorbunov FE; Golovach AV; Teniaeva EA; Krikorova SA; Sichinava NV; Tarasova LIu
    Vopr Kurortol Fizioter Lech Fiz Kult; 2005; (1):53-5. PubMed ID: 15759481
    [No Abstract]   [Full Text] [Related]  

  • 57. [Risk factors in the development of diabetic complications in children].
    Kniazev IuA; Martynova MI; Vakhrusheva LL; Dudnikova LK; Shiriaeva LI
    Pediatriia; 1988; (4):11-4. PubMed ID: 3205636
    [No Abstract]   [Full Text] [Related]  

  • 58. Glycation rates in type 1 diabetes mellitus.
    Wiener K; Roberts NB
    Ann Clin Biochem; 2000 Jan; 37 ( Pt 1)():93-6. PubMed ID: 10672383
    [No Abstract]   [Full Text] [Related]  

  • 59. Oxidative stress and diabetic complications in young IDDM patients.
    Elhadd TA; Jennings PE; Belch JJ
    Diabetes Care; 1997 Aug; 20(8):1338-9. PubMed ID: 9250466
    [No Abstract]   [Full Text] [Related]  

  • 60. Arguments for and against the role of glucose variability in the development of diabetes complications.
    Kilpatrick ES
    J Diabetes Sci Technol; 2009 Jul; 3(4):649-55. PubMed ID: 20144307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.